Thalidomide approved.
D017277:Drug Approval; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy; D013792:Thalidomide / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D007917:Leprostatic Agents; D013792:Thalidomide